Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013–2014 influenza season
Susanne L. Linderman(The Wistar Institute), Scott E. Hensley(University of Pennsylvania), Ali H. Ellebedy(Washington University in St. Louis), Benjamin S. Chambers(The Wistar Institute), Ted M. Ross(Cleveland Clinic), Donald M. Carter(Vaccine & Gene Therapy Institute of Florida), Sarah F. Andrews(National Institutes of Health), Yunping Huang(University of Chicago), Gustavo Reyes‐Terán, Richard L. Hodinka, Kaela Parkhouse(University of Pennsylvania), Seth J. Zost(Vanderbilt University Medical Center), Beth H. Shaz(Duke University), D Strauss(New York Blood Center), Christin Herrmann(The Wistar Institute), Jesse D. Bloom(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Min Huang(University of Science and Technology of China), Yang Li(Lanzhou Veterinary Research Institute), Patrick C. Wilson(Cornell University), Nai‐Ying Zheng(University of Chicago), Rafi Ahmed(Emory University)
Cited by 241
Related Papers
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Deployment of convalescent plasma for the prevention and treatment of COVID-19
|Journal of Clinical Investigation|2020|863